CHRONIC HEPATITIS B
Clinical trials for CHRONIC HEPATITIS B explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
DNA vaccine may let hepatitis b patients ditch daily pills
⭐️ VACCINE ⭐️ CompletedThis study tested a DNA vaccine in 70 adults with chronic hepatitis B who had undetectable virus levels from antiviral drugs. The goal was to see if the vaccine could train the immune system to keep the virus under control after stopping medication. Researchers measured how long …
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1, PHASE2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:53 UTC
-
New DNA vaccine shows promise for Hard-to-Treat hepatitis b
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a DNA vaccine in 10 adults with chronic hepatitis B who did not respond to standard treatments. The main goal was to see if the vaccine is safe and can help the immune system fight the virus. Researchers monitored for side effects and checked immune …
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:00 UTC
-
New shot aims to slash hepatitis b virus levels
Disease control CompletedThis study tested an experimental injection called RBD1016 in 48 adults with chronic hepatitis B who were already taking standard antiviral pills. The main goals were to see if the injection is safe and if it can lower hepatitis B surface antigen (HBsAg) levels in the blood. Part…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Suzhou Ribo Life Science Co. Ltd. • Aim: Disease control
Last updated May 17, 2026 08:13 UTC
-
New pill aims to control hepatitis b in early trial
Disease control CompletedThis early-phase study tested a new oral drug called AB-101 in 128 people, including healthy volunteers and patients with chronic hepatitis B. The main goal was to check safety and how the body processes the drug. It is not a cure, but a step toward better disease control.
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Arbutus Biopharma Corporation • Aim: Disease control
Last updated May 17, 2026 08:12 UTC
-
New combo therapy may help some hepatitis b patients stop daily pills
Disease control CompletedThis study tested a new drug called AB-729 combined with standard antiviral therapy and short courses of pegylated interferon in 43 adults with chronic hepatitis B. The goal was to see if the combination is safe and can lower hepatitis B surface antigen levels enough that patient…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Arbutus Biopharma Corporation • Aim: Disease control
Last updated May 17, 2026 08:01 UTC
-
New pill shows promise in early hepatitis b trial
Disease control CompletedThis early-stage study tested a new oral drug called ALG-000184 in 165 people, including healthy volunteers and patients with chronic hepatitis B. The main goal was to check if the drug is safe and how the body processes it. Researchers also looked at whether it can lower hepatit…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Experimental hepatitis b vaccines pass early safety check
Disease control CompletedThis early-stage study tested two experimental vaccines, GS-2829 and GS-6779, in 83 healthy volunteers and people with chronic hepatitis B. The main goal was to see if the vaccines were safe and tolerable. Researchers also looked for signs that the vaccines boosted the immune sys…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for hepatitis b: experimental drug shows promise
Disease control CompletedThis study tested an experimental drug called VIR-2218, given alone or with another medicine (peginterferon), in 84 adults with chronic hepatitis B. The goal was to check safety and how well the drug works against the virus. Researchers measured side effects and looked for drops …
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New combo therapy shows promise in taming chronic hepatitis b
Disease control CompletedThis study tested a new treatment, VTP-300, combined with a low dose of nivolumab, in 121 adults with chronic hepatitis B who were already on antiviral medication. The goal was to see if the combination could further reduce hepatitis B surface antigen levels. The approach aims to…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Barinthus Biotherapeutics • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
Fatty liver and pancreas common in hepatitis b patients, study finds
Knowledge-focused CompletedThis study measured how often fatty liver and fatty pancreas occur in 217 adults with chronic hepatitis B, comparing those who were obese versus lean. Researchers used a special ultrasound-like test to check for fatty liver and a regular ultrasound for fatty pancreas. The goal wa…
Matched conditions: CHRONIC HEPATITIS B
Sponsor: Tanta University • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC